SKLN - SKYLINE MEDICAL INC

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
1.21
-0.15 (-11.03%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close1.36
Open1.22
Bid0.00 x 0
Ask0.00 x 0
Day's Range1.14 - 1.37
52 Week Range1.14 - 1.37
Volume3,728,544
Avg. VolumeN/A
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire22 days ago

    Precision Therapeutics is the First Company to Grow Cancer Cells in the Lab That React Like Tumors Inside the Body -- CEOLIVE.TV

    ORLANDO, FL, April 04, 2018-- CEOLive.TV, a news organization that highlights leading CEOs, companies, and industry experts for investors, today released a video interview with Dr. Carl Schwartz, CEO of ...

  • ACCESSWIRE24 days ago

    Skyline Medical, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / April 2, 2018 / Skyline Medical, Inc. (NASDAQ: SKLN ) will be discussing their earnings results in their Q4 Earnings Call to be held on April 2, 2018 at 4:30 PM Eastern Time. ...

  • Should You Be Content With Precision Therapeutics Inc’s (NASDAQ:AIPT) Earnings Growth?
    Simply Wall St.last month

    Should You Be Content With Precision Therapeutics Inc’s (NASDAQ:AIPT) Earnings Growth?

    Increase in profitability and industry-beating performance can be essential considerations in a stock for some investors. In this article, I will take a look at Precision Therapeutics Inc’s (NASDAQ:AIPT) trackRead More...

  • GlobeNewswire3 months ago

    Precision Therapeutics, Formerly Skyline Medical, Announces Stock Ticker Symbol Change to AIPT

    MINNEAPOLIS, Feb. 02, 2018-- Precision Therapeutics Inc, formerly Skyline Medical Inc,, is pleased to announce that its NASDAQ Capital Market ticker symbol will change from' SKLN' to‘ AIPT' effective February ...

  • SmarterAnalyst3 months ago

    Skyline Medical Inc: Momentum Flowing Into 2018

    Skyline Medical Inc (NASDAQ:SKLN) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 33% upturn. The medical device maker announced that it currently projects sales of approximately 100 STREAMWAY Systems in 2018. These projections, if realized would represent a 10x increase over the Company’s 2017 sales figures. In late 2017, the Company ramped up its U.S. sales and marketing campaign for the STREAMWAY system which resulted in a meaningful increase in domestic sales in the fourth quarter of 2017 and early 2018.

  • GlobeNewswire3 months ago

    Skyline Medical Projects 100 STREAMWAY System Sales in the U.S. in 2018

    MINNEAPOLIS, Jan. 31, 2018-- Skyline Medical Inc., is pleased to announce that it currently projects sales of approximately 100 STREAMWAY Systems in 2018. This projection is based on ongoing negotiations ...

  • GlobeNewswire3 months ago

    Skyline Medical Opens New European Headquarters to Drive International Sales of the STREAMWAY System

    MINNEAPOLIS, Jan. 26, 2018-- Skyline Medical Inc, today announced that it has opened new European headquarters in Belgium and appointed Jean-Paul Rasschaert as Vice President of International Sales to ...

  • ACCESSWIRE4 months ago

    D-CHIP from Helomics and Skyline Medical Targets Explosive Growth in Artificial Intelligence Healthcare Market

    Big Data and Artificial Intelligence in Healthcare Predicted to Become $100 Billion Per Year Market, According to McKinsey Report EAGAN, MN / ACCESSWIRE / January 9, 2018 / CEOCFO Magazine , an independent ...

  • American City Business Journals4 months ago

    Skyline takes stake in Helomics

    Skyline Medical Inc. is purchasing an equity stake in Helomics Corp., acquiring up to 25 percent of the Pittsburgh-based precision diagnostic company. Skyline (SKLN), producer of an FDA-approved system for automated, direct-to-drain medical fluid disposal, is purchasing preferred stock convertible into 20 percent of the outstanding common stock of Helomics, representing 20 percent of the company, in exchange for total consideration of 1.1 million shares of newly issued Skyline common stock. Skyline also has the right to convert a previous $500,000 loan to Helomics into a further 5 percent equity stake.

  • Does Zero-Debt Make Skyline Medical Inc (NASDAQ:SKLN) A Financially Strong Company?
    Simply Wall St.4 months ago

    Does Zero-Debt Make Skyline Medical Inc (NASDAQ:SKLN) A Financially Strong Company?

    Zero-debt allows substantial financial flexibility, especially for small-cap companies like Skyline Medical Inc (NASDAQ:SKLN), as the company does not have to adhere to strict debt covenants. However, it also facesRead More...

  • Skyline Medical, Inc. :SKLN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
    Capital Cube5 months ago

    Skyline Medical, Inc. :SKLN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017

    Categories: Yahoo FinanceGet free summary analysis Skyline Medical, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Skyline Medical, Inc. – Edwards Lifesciences Corporation and Intuitive Surgical, Inc. (EW-US and ISRG-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 0.15 ... Read more (Read more...)

  • ACCESSWIRE5 months ago

    Skyline Medical's Streamway System Gains Credibility with Hospitals

    EAGAN, MN / ACCESSWIRE / November 20, 2017 / CEOCFO Magazine , an independent investment publication that highlights important technologies and companies, today explains how leading hospitals are beginning ...